Harel Insurance Investments & Financial Services Ltd. Kamada LTD Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Oct 20, 2020	SELL	$8.02 - $11.73 $42,506 - $62,169	-5,300 Closed	0 $0
Q2 2020 Jul 14, 2020	BUY	$5.37 - $9.45 $28,461 - $50,084	5,300 New	5,300 $41,000

Others Institutions Holding KMDA

# of Institutions

Shares Held

6.48M

Call Options Held

200

Put Options Held

Phoenix Holdings Ltd. Givatayim, L3

1.83M
Shares

$11.1 Million
0.15% of portfolio
Vanguard Group Inc Valley Forge, PA

1.38M
Shares

$8.38 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

856K
Shares

$5.18 Million
0.01% of portfolio
Y.D. More Investments LTD Ramat Gan, L3

710K
Shares

$4.29 Million
0.4% of portfolio
Wells Fargo & Company San Francisco, CA

630K
Shares

$3.81 Million
0.0% of portfolio

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $271M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account